Aortic atheromatous plaques regress slowly in cholesterol-fed rabbits that have been returned to normal laboratory diet. To delineate metabolic factors potentially responsible for persistence of atherosclerosis under these conditions, the physical, chemical, and metabolic characteristics were determined for lipoproteins of d < 1.006 g/ml; such lipoproteins are thought to be the major determinant of progression of atherosclerotic lesions in cholesterol-fed rabbits. At the time of return to a normal laboratory diet regimen after 3 mo of feeding with cholesterol-enriched laboratory diet, plasma cholesterol concentrations were 2,275±252 mg/dl, mostly attributable to cholesteryl ester-rich very low density lipoproteins (VLDL). On the hypercholesterolemic diet, fractional catabolic rates of plasma clearance of 1251-labeled VLDL were reduced (0.011±0.002 vs. 0.151±0.015 h-'), but the total VLDL catabolic rate was increased considerably (17.1±2.2 vs. <1.2±0.4 mg of protein/kg.d), because of the expansion of the endogenous pool ofcholesteryl ester-rich VLDL. The total catabolic rate of VLDL was maintained above estimated control values (5.8±0.7 mg protein/kg . d) even 10 wk after return of the rabbits to a normal chow regimen, an effect attributable to continued high rates of cholesteryl ester-rich VLDL synthesis in liver. Accumulation of cholesteryl ester-rich VLDL into aortic tissue persisted at a high rate. Thus the persistence of aortic atheromatous lesions after cessation of cholesterol feeding was attributable in part to continued high rates of hepatic production of cholesteryl ester-rich VLDL and its persistent delivery into the aortic wall.
Introduction
Atherosclerotic vascular disease is the leading cause ofmortality in the Western industrial countries. In view of the prevalence of atherosclerosis, mechanisms by which atherosclerotic lesions may regress are of particular interest. Regression of established atheromatous lesions has been studied in several species exposed to modified diets or drugs (1) including rabbits previously fed cholesterol-supplemented diets. The rabbit responds very rapidly to changes in dietary cholesterol with increased concentrations of plasma cholesterol, changed lipoprotein profiles, and the appearance of extensive atheromatous lesions in the aorta. The Dr. Schonfeld is with the Lipid Research Center, Washington University School of Medicine.
Received for publication 4 December 1984 and in revised form 12 December 1985. extent of regression of aortic atheromatous lesions in cholesterolfed rabbits returned to normal laboratory diet regimens is controversial (2, 3) . Judging from determinations of cholesterol in the entire aorta, little or no regression occurs in the first 3 mo after cessation of the high cholesterol diet (4) (5) (6) . In fact, paradoxical increases in aortic cholesterol content may occur after cessation of the atherogenic diet (7) . Although mechanisms responsible for the slow regression of aortic atheromatous lesions in previously cholesterol-fed rabbits have been shown to include a slow rate of return of plasma cholesterol concentrations to normal levels (2) , factors responsible for the persistent hypercholesterolemia and the persistent atherogenesis have not been elucidated.
Associations have been reported between the frequency of occurrence of atheromatous lesions and the appearance in plasma of cholesterol-fed dogs of very low density lipoprotein, (VLDL) which is enriched in cholesteryl esters and which migrates electrophoretically in the (3-position (8) . VLDL obtained from hypercholesterolemic rabbits is a powerful stimulant of cholesterol ester formation in cultured cells (9) . Furthermore, labeled VLDL from hypercholesterolemic rabbits accumulates in rabbit aortic atheromatous lesions both in vitro (10) and in vivo (11) . Hence VLDL in plasma of continuous cholesterolfed rabbits appears to be potentially atherogenic.
The present study was designed to identify metabolic factors potentially responsible for the slow regression of aortic plaques in cholesterol-fed rabbits returned to normal laboratory diet, by analysis of plasma concentrations, composition, kinetics of clearance, and aortic uptake of the potentially atherogenic lipoprotein, VLDL. Our results demonstrate increased flux of VLDL-protein through plasma and enhanced aortic accumulation ofVLDL-protein and cholesterol in association with intake of a cholesterol-enriched diet. The observed abnormalities including aortic accumulation of VLDL-protein persisted for at least 10 weeks after return of the hypercholesterolemic rabbits to a normal laboratory diet.
Methods
Dietary regimens and experimental design. New Zealand rabbits (3-3.5 kg) were obtained from a single source (Eldridge Laboratory Animals, St. Louis, MO) and housed individually in stainless steel cages. Food and water were available ad libitum. Four groups of recipient rabbits were used: Group I was fed a 2% wt/wt cholesterol-enriched diet for 11-13 wk, then returned to normal laboratory diet, and studied after 0, 4, and 1O wk of normal feeding of laboratory diet. Group 2 was fed normal laboratory diet, and studied at an interval corresponding to those for group 1 To determine whether cholesteryl ester-rich VLDL from continuously cholesterol-fed rabbits was a suitable tracer for use in animals returned to normal laboratory diet, VLDL was isolated from a cholesterol-fed rabbit and from a hypercholesterolemic rabbit that had been returned to normal laboratory diet for 10 wk. These lipoproteins were radiolabeled with 131I and 1251, respectively. Radiolabeled VLDL preparations were then injected simultaneously into continuously cholesterol-fed rabbits and hypercholesterolemic animals that had been returned to normal laboratory diet for 10 wk.
After correction for spillover of '311 radioactivity into the '"I channel, radioactivity was expressed as counts per minute per milliliter ofplasma. The calculated radioactivity present at 0 min was estimated from the injected counts divided by the calculated plasma volume and regarded as the 100% value. Radioactivity at each subsequent interval was expressed as a percentage of the zero time value.
Kinetics of plasma clearance of 125I-and 131i-labeled lipoproteins were analyzed by the method of Matthews (15) as described previously (1 1). Total catabolic rates were calculated as the product ofthe fractional catabolic rate and pool size in plasma. In rabbits in which endogenous pools were below limits of detection (<1 mg/dl for lipoprotein protein), it was not possible to calculate total catabolic rates definitively. Consequently, estimates were based on an assumed plasma concentration of 1 mg/dl. These estimates, although subject to error, provide reasonable boundary values for kinetic parameters. The parameters were so dramatically different from those in other groups that they are included for comparison.
24 h after injection of the radiolabeled lipoprotein, blood samples taken from the central ear artery were placed into tubes containing EDTA (1.5 mg/ml). 3-ml samples of plasma were fractionated by sequential ultracentrifugation with density cuts (g/ml) d < 1.006, 1.006-1.063, d > 1.21. Each centrifugation was performed with Beckman Quick-Seal tubes in a 4OTi rotor centrifuged at 40,000 rpm for 18 h at 14WC in a Beckman L8-55 ultracentrifuge. Cholesterol content and radioactivity were determined for each density cut and expressed as percentages in each fraction of total counts.
Determination ofplasma volume. Calculation of fractional catabolic rate required an accurate assessment of plasma volume for calculation ofthe concentration ofradioactivity present in plasma immediately after injection ofradiolabel. This consideration is particularly pertinent to the present study because plasma volume may change after cholesterol feeding in rabbits (16) . Two common methods of determination of plasma volume involve use of Evans blue or '25I-labeled albumin. Neither was used in this study because the hyperlipidemic plasma represents a source of error in the spectrophotometric measurement of dye and because longterm housing of radioactive animals is logistically difficult. Instead, a vascular tracer, transferrin, was labeled with the positron-emitting isotope gallium-68 (68Ga) providing advantages attributable to its short physical half-life (68 min). Approximately 0.5 mCi of generator-produced 68Ga coupled to transferrin was injected into the marginal ear vein of the rabbit and blood samples taken at 5 and 15 min from the vein of the opposite ear. Plasma radioactivity was determined with a Beckman gamma counter. After correction for radioactive decay ofssGa, the activity in plasma was extrapolated to 0 time and plasma volume calculated. Calculated plasma volume of rabbits maintained on normal laboratory diet was 28±2 ml/kg (n = 4) compared with 33±2 ml/kg (n = 4) for the hypercholesterolemic group.
Preparation ofaortic and hepatic tissues. 24 h after injection of the radiolabeled lipoproteins in the experiments performed 10 wk after return to a normal laboratory diet regimen, the rabbits were killed with an Very Low Density Lipoproteins and Regression 1109 overdose of pentobarbital. Visceral and thoracic cavities were opened rapidly and irrigated with cold saline. Aortas were exposed from the arch to the bifucation and removed. Extraneous tissue was dissected free and the aortas cut to expose the intimal surface. This procedure required , 15 min. Five aortic segments were prepared: arch and upper thoracic, thoracic, upper, mid-and lower abdominal as described previously (1 1). Segments were blotted lightly and weighed. Samples were then frozen in 12 X 75-mm test tubes. Radioactivity of 125I and '"'I in the still frozen samples was determined simultaneously with an Isoflex gamma counter. After radioactivity had been determined, the tissues were thawed and homogenized in sodium chloride (0.15 M, pH 7.4) with a Polytron (Brinkmann Instruments, Westbury, NY). Homogenized tissue was extracted according to the Bligh and Dyer procedure (17) . The organic phase was removed and prepared for determination of cholesterol. The aqueous phase was incubated with trichloroacetic acid (10% wt/vol) for 1 h at 4VC followed by centrifugation at 3,000 rpm for 30 min in a Beckman J6 centrifuge. The supernatant fraction was decanted and radioactivity of 125I and "3i determined in both infranate and supernate.
Spill-over of "3'I radioactivity into the 1251I channel was corrected in all measurements. To calculate mass of lipoprotein-protein present in aorta segments, the median specific activity of lipoprotein-protein was calculated from the area under the specific radioactivity-time-plasma clearance curves. Areas were determined with a Hewlett Packard 9864A digitizer (Hewlett-Packard Co., Palo Alto, CA).
Livers were excised and weighed. A segment from each was extracted according to the Bligh and Dyer procedure (17) . The organic phase was removed and dried under nitrogen. Extracted material of hepatic and aortic tissue was then resuspended in isopropyl alcohol. Total cholesterol was determined enzymatically with commercial test kits (Boehringer Mannheim).
Statistical analysis. Values are means±standard error of the mean.
Student's t test (two-tailed) was used to determine statistical significance with a probability level of <5%.
Results
Concentrations ofplasma lipids. Three experimental groups were used including rabbits fed normal laboratory diet, a group fed a cholesterol-enriched diet for 12 wk, and rabbits fed a cholesterol-containing diet for 12 wk followed by normal laboratory diet for 10 wk. As has been documented previously, cholesterol feeding elevated plasma cholesterol concentrations grossly (Fig.  1 A) . Hyperphospholipidemia was present in the cholesterol-fed (576±75 mg/dl) compared to values in normal laboratory dietfed animals (94±22 mg/dl). After return of animals to normal laboratory diet, plasma cholesterol concentrations declined only slowly. 10 wk after return to normal laboratory diet, plasma cholesterol concentrations were 351±35 mg/dl, which was still grossly elevated compared with values in concurrent controls (80±11 mg/dl). Hyperphospholipidemia regressed slowly also, but plasma concentrations at 10 wk were no longer significantly greater than those in controls (178±28 compared with 98±21 mg/dl). No changes were observed in plasma concentrations of triglycerides during the period of return to normal laboratory diet.
Most of the increased plasma cholesterol in continuously cholesterol-fed animals was in the d < 1.006 g/ml fraction (Table  I) terol-fed group (o, n = 4), and the hypercholesterolemic group returned to a normal diet regimen (o, n = 4). The time axis represents the number of weeks after the hypercholesterolemic animals had been returned to normal laboratory diet. At week 10, a group of continuously cholesterol-fed animals was studied concomitantly with the normal diet fed and previously cholesterol-fed rabbits. Values were measured 0, 4, and 10 wk after the hypercholesterolemic group had been returned to a normal diet regimen and are means±standard errors. *P < 0.05; **P < 0.01. phoretic mobility, and size distribution. VLDL (Table II) . Changes in electrophoretic mobility of plasma VLDL on agarose gels were noted after hypercholesterolemic rabbits had been returned to normal laboratory diet. During the interval of cholesterol feeding, plasma VLDL migrated exclusively in the i position. After animals had been returned to normal diet electrophoretic mobility of plasma VLDL became greater, but migration was still not in the pre-f3 position even after 10 wk (Fig. 2) .
VLDL harvested from continuously cholesterol-fed rabbits contained predominantly apolipoprotein E (66%) and apolipoprotein B (28%), and small quantities of apolipoprotein C's (16%). As a function of the duration of feeding of normal diet, the VLDL was relatively depleted of apolipoprotein E with an increased presence of apolipoprotein C (28% at week 10; Fig. 3 ).
Distribution of subfractions of VLDL was characterized after return to normal laboratory diet by high performance liquid chromatography. VLDL from rabbits at time of return to normal diet was resolved into two major subfractions. A large sized subfraction (FxI) eluted in the void volume at 23 min and the other (FxII) eluted at 29 min (Fig. 4 A) . Distribution ofcholesterol was principally (>95%) in FxII although the cholesterol content of FxI was clearly discernible (Fig. 4 D) . At week 4, FxI was barely detectable by optical density at 280 min (Fig. 4 B) . It did not contain significant amounts of cholesterol (Fig. 4 E) after cholesterol feeding (Fig. 1 C; see also Fig. 5 B) . After 24 h, 7% of initially injected 125I was present in the plasmas of rabbits fed laboratory diet. In contrast, 36% was present in the cholesterol-fed group. Fractional catabolic rate of '251I-labeled VLDL was 0.01 1±0.004 h-' for the hypercholesterolemic group after 12 wk of intake of the cholesterol-enriched diet (Fig. 1 B) . In the concurrently studied normal diet-fed group, the fractional catabolic rate was 0.151±0.012 h-'. Although the fractional catabolic rate was decreased, the highly elevated plasma concentrations of VLDL protein indicated that total catabolic rates remained high in these groups (17.1±2.2 compared with < 1.2±0.4 mg of protein/kg -d for cholesterol and normal laboratory diet-fed groups). Because cholesteryl ester-rich VLDL is not present in detectable quantities in rabbits fed laboratory diet, the total catabolic rate was estimated only by assigning an upper boundary on an assumed VLDL pool size. Thus the estimated rate cannot be taken as definite. Nevertheless, if errors are present they would be likely to magnify the already large differences between the calculated values among groups. Over the 24 h during which kinetics of plasma clearance were determined, a steady concentration of lipoprotein in plasma was assumed supported by the lack of significant changes in plasma cholesterol concentrations. Judging from an assumed steady state for rates of synthesis and degradation over the course of the experiment, the elevated concentrations of cholesteryl ester-rich VLDL appeared to reflect increased rates of synthesis as demonstrated previously ( 11) . In addition to differences in kinetics ofplasma clearance, differences in redistribution of 1251 between lipoprotein fractions were observed (Table III) . 24 h after injection of 251-labeled VLDL, very little redistribution of '251-label was found, i.e., 90±3% of 125I remained in the d < 1.006 g/ml fraction in rabbits fed cholesterol for 12 wk. In contrast, in rabbits fed normal laboratory diet there was substantial redistribution into other fractions with only 40±1% remaining in the d < 1.006 g/ml fraction after 24 h (Table III) . Plasma clearance of '251-labeled VLDL was assessed again 4 and 10 wk after the group of hypercholesterolemic rabbits had been returned to a normal diet regimen (Fig. 1) . At 4 wk there was some reduction in the fractional catabolic rate compared to values at week 0 (0.019±0.004 vs. 0.011±0.004 h-') although the total catabolic rate remained high (19.8±2.4 mg of protein/ kg-d). At 10 wk, the fractional catabolic rate had increased (0.043±0.008 h-') and the total catabolic rate was reduced (5.8±0.7 mg of protein/kg. d; Fig. 1 D) . However, values remained significantly different from those estimated in normal diet-fed animals. In keeping with these trends of reversal, redistribution of 125I after administration of I251-labeled VLDL to rabbits was noted 4 and 10 wk after cessation of cholesterol diet with progressively less radioactivity in the d < 1.006 g/ml fraction (80±3% and 70±3%, respectively, Table III ).
To evaluate the suitability of using '251-labeled cholesteryl ester-rich VLDL harvested from a continuously cholesterol-fed rabbit as the tracer for VLDL during the period of return to normal laboratory diet, a crossover kinetic experiment was performed. VLDL was harvested from a continuously cholesterolfed rabbit and from one returned to normal diet for 10 wk. VLDL from each was radioidinated with "'I and 1251, respectively. A mixture of the two radiolabeled VLDL preparations was injected into cholesterol-fed rabbits as well as into animals which had been returned to normal diet for 10 wk. Both components of the mixture of 125I-and "3'1-labeled VLDL exhibited similar kinetics of plasma clearance in cholesterol-fed rabbits (n) Number of animals in each group. RNC, group previously fed cholesterol-enriched diet and studied at the times indicated after return to normal laboratory diets. NC, group fed normal laboratory diet ("chow") and studied concurrently with RNC group. CF, group fed cholesterol diet continuously for 12 wk and studied at week 10.
(fractional catabolic rates of 0.015 and 0.0 14 h-1, respectively; Fig. 5 B) . In rabbits returned to normal diet for 10 wk the plasma clearance ofVLDL harvested from a cholesterol-fed animal was slower than that of the VLDL obtained from rabbits returned to normal diet (fractional catabolic rates of0.031 and 0.021 h-1, respectively; Fig. 5 A) . Although significant, the magnitude of the difference was modest. Thus the VLDL harvested from cholesterol-fed rabbits was regarded as a tracer appropriate for characterization ofkinetics ofplasma clearance of VLDL during the interval in which hypercholesterolemic rabbits were returned to normal diet regimens. Tissue cholesterol content. After cholesterol feeding aortic tissue cholesterol content was increased greatly in all sections. Tissue cholesterol content was even higher in hypercholesterolemic rabbit aortas 10 wk after the animals had been returned to a normal laboratory diet regimen (Fig. 6 ).
Although it was not possible to quantify the percentage of intimal area that was covered by definable atherosclerotic lesions, gross visual inspection showed more extensive areas of intima covered by atherosclerotic plaques in hypercholesterolemic rabbits returned to normal diet compared with regions in the group fed a cholesterol diet for 12 wk. This impression was supported by quantitative determinations of cholesterol.
Cholesterol feeding resulted in larger "fatty" livers with increased concentrations of cholesterol (Fig. 7) . Marked reductions of hepatic mass and hepatic concentration of cholesterol were noted 10 wk after animals had been returned to a normal laboratory diet regimen compared with values in the continuously cholesterol-enriched diet-fed group, although hepatic cholesterol concentrations were significantly greater than those in normal diet-fed animals (P < 0.01).
Aortic accumulation of radiolabeled VLDL. Accumulation ofcholesteryl ester rich-VLDL protein over 24 h was considerably higher in aortas of cholesterol-fed animals than in aortas from control animals (Fig. 8) . 89±3% of 1251 present in aortas of cholesterol-fed rabbits was precipitable by trichloroacetic acid. Only 26±4% was precipitable in aortas of laboratory diet-fed rabbits. When hypercholesterolemic animals were studied 10 wk after they had been returned to normal diet, less VLDL protein accumulated in aortic tissue than in aortas of continuously cholesterol-fed rabbits, but accumulation was greater than that observed in normal diet-fed animals (Fig. 8) . A lower proportion of 1251 was trichloracetic acid-precipitable in hypercholesterolemic rabbits returned to normal diet (68±4%) compared with amounts precipitable in extracts from the cholesterol-fed group.
Discussion
Results obtained in this study imply that specific aspects of metabolism of cholesteryl ester-rich VLDL may account for the lack of regression of atheromatous lesions in rabbits subjected to 12 weeks of a cholesterol-enriched diet. Morphologically, the atheromatous plaques formed during cholesterol feeding are somewhat similar to fatty streaks in human aortas. Such fatty streaks exhibit intracellular lipid deposition within foam cells, with some extracellular lipid accumulation. It has been speculated that such lesions are precursors of the more complex fibrolipid plaques in nonhuman primates (19) and in humans (20) . Because the fatty streak may represent an early phase of atheromatous plaque formation, it would be anticipated to be one of the lesions most susceptible to reversal. However, results from studies that have quantified the extent of regression in previously cholesterol-fed rabbits have been equivocal (2) .
The present study attempted to define the biochemical mechanisms responsible for lack of regression in the fatty streak stage in previously cholesterol-fed rabbits. In agreement with Gupta et al. (7), we noted an increase in aortic cholesterol content after hypercholesterolemic rabbits had been returned to normal laboratory diet for 10 wk, compared to values in animals fed the cholesterol-enriched chow continuously for 12 wk. To account for the lack of regression, we considered the possibility that the persistence of aortic atheromatous plaques in previously cholesterol-fed rabbits might be attributable to continued delivery ofcholesterol, via cholesteryl ester-rich VLDL, and perhaps also intermediate density lipoprotein and low density lipoprotein (LDL) to the arterial wall. The metabolism of cholesteryl esterrich VLDL was chosen for characterization because it appears rapidly and in large quantities in the plasma of cholesterol-fed rabbits. Cholesteryl ester-rich VLDL was also of particular interest because of the correlation between elevated concentrations of this lipoprotein in plasma and appearance of atheroma (8-1 1), and the fact that cholesteryl ester-rich VLDL is known to produce cholesterol loading in cells (9) .
Feeding rabbits a high-cholesterol diet produced the expected hypercholesterolemia, accumulation of cholesteryl ester-rich VLDL in plasma, gross increases in hepatic and aortic cholesterol content, and aortic atherosclerotic plaques. 10 
And~~
High rates of synthesis of cholesteryl ester-rich VLDL were remarkably persistent. Marked reductions of hepatic concentrations of cholesterol, albeit not entirely to normal, were evident suggesting that the continuing rapid flux ofcholesteryl ester-rich VLDL after return to normal chow was attributable to continuing high rates of secretion of the lipoprotein by the liver.
In contrast to the case for liver, the cholesterol content of the aortic tissue continued to increase after animals had been returned to a normal laboratory diet regimen. In addition to increased cholesterol content, accumulation of VLDL protein was elevated over that in laboratory diet-fed rabbits even 10 wk after the cholesterol-fed animals had been returned to normal diet. Thus enhanced delivery of cholesteryl ester-rich VLDL to the aortic tissue appeared to continue to promote the deposition of cholesterol esters. The continuing rise in aortic cholesterol raises the additional possibility that rates ofremoval ofcholesterol from the arterial wall were defective. The extent to which VLDL accumulated intra-or extracellularly is not clear, nor is it known whether cellular receptors for (3-VLDL or LDL mediated intracellular accumulation and whether or not this changed over time.
The d < 1.006 g/ml plasma fraction of cholesterol-fed animals and type III hyperlipidemic subjects has been fractionated further using Sepharose 4B column chromatography (21) (22) (23) . As demonstrated by the high performance liquid chromatographic separation, we found that rabbit cholesteryl ester-rich VLDL comprised two major fractions. The fraction eluted in the void volume does not represent aggregates of the small sized fraction because the two peaks have distinct chemical compositions. The larger sized fractions ofcholesterol ester-rich VLDL possess very little protein, and consequently the vast majority of the radioactivity of 125I-labeled VLDL is associated with the smaller sized fraction when prepared for donor lipoproteins of cholesterol-fed rabbits (data not shown). Only the small sized fraction is present in plasma ofcholesterol-fed rabbits when they are returned to normal diet (23) , probably reflecting the fact that the larger sized fraction is of intestinal origin and the smaller is synthesized in the liver. Radioiodination ofwhole VLDL attaches -95% of the radioactivity to the smaller-sized fraction, and consequently the '25I-labeled VLDL prepared from the cholesterol-fed rabbits would have traced primarily the smaller fraction. The crossover kinetics of plasma clearance experiments demonstrated that VLDL obtained from continuously cholesterolfed rabbits was cleared more slowly from plasma of rabbits returned to normal laboratory diet for 10 wk than their own VLDL. Thus, use ofboth radiolabels simultaneously demonstrated that the apparent magnitude of cholesteryl ester-rich VLDL accumulation was affected by the source ofdonor '251I-labeled VLDL in the hypercholesterolemic group that was returned to normal laboratory diet. However, because the effect was relatively small, the major conclusions of this study were confirmed using both labels, namely that excess aortic accumulation persisted even after 10 wk of feeding of normal laboratory diet.
The larger-sized VLDL fraction is the most potent in eliciting cholesterol ester deposition in cultured macrophages (21) . It has been implicated as a mediator ofatherogenic effects ofcholesteryl ester-rich VLDL (24) . However, in hypercholesterolemic rabbits returned to normal diet, marked deposition of cholesterol in aortic vessel wall persisted even though only the smaller sized cholesterol-enriched VLDL fraction was detectable in plasma.
The principal tissue site for catabolism of cholesteryl esterrich VLDL is the liver (25) . Uptake of VLDL in the liver is mediated by apolipoprotein E. This process is inhibited by apolipoprotein C (26, 27) . However, VLDL harvested from cholesterol-fed animals, which has only trace amounts of apolipoprotein C, was cleared more slowly from plasma than VLDL harvested from rabbits returned to normal laboratory diet, which contains appreciable quantities of apolipoprotein C.
In summary, our results suggest that persistence of aortic atheromatous plaques in previously cholesterol-fed rabbits returned to a normal laboratory diet regimen is attributable in part to a continuing enhanced accumulation in the arterial wall of the atherogenic lipoprotein, cholesteryl ester-rich VLDL, possibly combined with an impaired reverse transport of cholesterol associated with diminution of the concentration of high density lipoprotein in plasma.
